References
: 1- Paithankar JG, Saini S, Dwivedi S, Sharma A, Chowdhuri DK. Heavy metal associated health hazards: An interplay of oxidative stress and signal transduction. Chemosphere. 2021;262:128350. 2- He ZL, Yang XE, Stoffella PJ. Trace elements in agroecosystems and impacts on the environment. J Trace Elem Med Biol. 2005;19(2–3):125–140. 3- Zhao L, Islam R, Wang Y, Zhang X, Liu LZ. Epigenetic regulation in chromium-, nickel- and cadmium-induced carcinogenesis. Cancers. 2022;14(23):5768. 4- Renu K, Chakraborty R, Myakala H, Koti R, Famurewa AC, Madhyastha H, Vellingiri B, George A, Valsala Gopalakrishnan A. molecular mechanism of heavy metals (Lead, Chromium, Arsenic, Mercury, Nickel and Cadmium)-induced hepatotoxicity—A review. Chemosphere. 2021;271:129-137. 5- International Agency for Research on Cancer (IARC): Working Group on the Evaluation of Carcinogenic Risks to Humans. Arsenic, metals, fibres, and dusts. A Review of Human Carcinogens. Lyon, France. 2012;1-52. 6- Islam R, Zhao L, Wang Y, Lu-Yao G, Liu LZ. Epigenetic dysregulations in arsenic- induced carcinogenesis. Cancers. 2022;14(18):4502. 7- World Health Organization. Cancer. [Internet]. 2023 [cited 2023 Oct 6]. 8- Available:https://www.who.int/health-topics/cancer#tab=tab_1 9- Kim HS, Kim YJ, Seo YR. An overview of carcinogenic heavy metal: Molecular toxicity mechanism and prevention. J Cancer Prev. 2015;20:232–240. 10- Baylin SB, Ohm JE. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6(2):107–116. 11- Martinez-Zamudio R, Ha HC. Environmental epigenetics in metal exposure. Epigenetics. 2011;6:820–827. 12- Kanwal R, Gupta S. Epigenetic modifications in cancer. Clin Genet. 2012;81(4):303–311. 13- Mani? L, Wallace D, Onganer PU, Taalab YM, Farooqi AA, Antonijevi? B, Djordjevic AB. Epigenetic mechanisms in metal carcinogenesis. Toxicol Rep. 2022;9:778-787. 14- Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M. Global cancer observatory: Cancer today. Lyon: International Agency for Research on Cancer. [Internet]. 2020 [cited 2021 Feb].Available:https://gco.iarc.fr/today. 15- American Cancer Society. The Cancer Atlas. The Burden of Cancer. [Internet]. 2022 [cited 2022 Jan]. Available:The Cancer Atlas website 16- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. 17- World Health Organization. Cancer. [Internet]. 2022 [cited 2022]. Available from: 18- Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016;17:487-500. 19- Wang B, Li Y, Shao C, Tan Y, Cai L. Cadmium and its epigenetic effects. Curr Med Chem. 2012;19:2611-20. 20- Henikoff S, Greally JM. Epigenetics, cellular memory and gene regulation. Curr Biol. 2016;26(14):R644-8. 21- Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23-38. 22- Kaplun DS, Kaluzhny DN, Prokhortchouk EB, Zhenilo SV. DNA methylation: genomewide distribution, regulatory mechanism and therapy target. Acta Naturae. 2022;14(4):4-19. 23- McMahon KW, Karunasena E, Ahuja N. The Roles of DNA Methylation in the Stages of Cancer. Cancer J. 2017;23(5):257-61. 24- Nevin C, Carroll M. Sperm DNA Methylation, Infertility and Transgenerational Epigenetics. J Hum Genet Clin Embryol. 2015;1. 25- Cox M, Nelson DR, Lehninger AL. Lehninger Principles of Biochemistry. W.H. Freeman; 26- Audia JE, Campbell RM. Histone Modifications and Cancer. Cold Spring Harb Perspect Biol. 2016;8:19-34. 27- Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21:381–395. 28- Greer EL, Shi Y. Histone methylation: A dynamic mark in health, disease, and inheritance. Nat Rev Genet. 2012;13:343–357. 29- Kouzarides T. Chromatin Modifications and Their Function. Cell. 2007;128:693–705. 30- Renaude E, Marie K, Borg C, Peixoto P, Hervouet E, Loyon R, et al. Epigenetic reprogramming of CD4+ Helper T cells as a strategy to improve anticancer immunotherapy. Front Immunol. 2021;12:669992. 31- Morris KV (Ed.). Non-coding RNAs and Epigenetic Regulation of Gene Expression: Drivers of Natural Selection. Caister Academic Press; 2012. 32- Yan H, Bu P. Non-coding RNA in cancer. Essays Biochem. 2021;65:625–639. 33- P. Sen and M. Costa, Induction of chromosomal damage in Chinese Hamster Ovary cells by soluble and particulate nickel compounds: preferential fragmentation of the heterochromatic long arm of the X-chromosome by carcinogenic crystalline NiS particles, Cancer Res., 1985, 45, 2330–2325. 34- W. Lee, C. Klein, B. Kargacin, K. Salnikow, J. Kitahara, K. Dowjat, A. Zhitkovich, T. Christie and M. Costa, Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens, Mol. Cell. Biol., 1995, 15, 2547–2557 CAS . 35- B. Govindarajan, R. Klafter, M. Miller, C. Mansur, M. Mizesko, X. Bai, K. LaMotagne and J. Arbiser, Reactive oxygen-induced carcinogenesis cause hypermethylation of p16 (Ink4a) and activation of MAP kinase, Mol. Med., 2002, 8, 1–8 CAS . 36- M. Costa, K. Salnikow, S. Consentino, C. Klein, X. Huang and Z. Zhuang, Molecular mechanisms of nickel carcinogenesis, Environ. Health Perspect., 1991, 102, 127–130. 37- K. Conway, X. Wang, L. Xu and M. Costa, Effect of magnesium on nickel-induced genotoxicity and cell transformation, Carcinogenesis, 1987, 8, 1115– 1121 CrossRef CAS . 38- N. Borochov, J. Ausio and H. Eisenberg, Interaction and conformational changes of chromatin with divalent ions, Nucleic Acids Res., 1984, 12, 3089–3096 CrossRef CAS . 39- A. Karaczyn, F. Golebiowski and K. S. Kasprzak, Truncation, deamidation and oxidation of histone H2B in cells cultured with nickel(II), Chem. Res. Toxicol., 2005, 18, 1934– 1942 CrossRef CAS . 40- A. Karaczyn, S. Ivanov, M. Reynolds, A. Zhitkovich, K. S. Kasprzak and K. Salnikow, Ascorbate depletion mediates up-regulation of hypoxia-associated proteins by cell density and nickel, J. Cell. Biochem., 2006, 97, 1025–1035 CrossRef CAS . 41- L. Broday, W. Peng, M. H. Kuo, K. Salnikow, M. Zoroddu and M. Costa, Nickel compounds are novel inhibitors of histone H4 acetylation, Cancer Res., 2000, 60, 238– 241 CAS . 42- H. Chen, Q. Ke, T. Kluz, Y. Yan and M. Costa, Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing, Mol. Cell. Biol., 2006, 26, 3728– 3737 CrossRef CAS . 43- Q. Ke, T. Davidson, H. Chen, T. Kluz and M. Costa, Alterations of histone modifications and transgene silencing by nickel chloride, Carcinogenesis, 2006, 27, 1481– 1488 CrossRef CAS . 44- F. Golebiowski and K. S. Kasprzak, Inhibition of core histones acetylation by carcinogenic nickel(II), Mol. Cell. Biochem., 2005, 279, 133–139 CrossRef CAS . 45- C. Klein and M. Costa, DNA methylation, heterochromatin and epigenetic carcinogens, Mutat. Res., 1997, 386, 163–80 CAS . 46- C. Klein, K. Conway, X. Wang, K. Bhamra, X. Lin, M. Cohen, L. Annab, J. Barrett and M. Costa, Senescence of nickel-transformed cells by an X-chromosome: possible epigenetic control, Science, 1991, 251, 796–799 CrossRef CAS . 47- Y. Yan, T. Kluz, P. Zhang, H. Chen and M. Costa, Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure, Toxicol. Appl. Pharmacol., 2003, 190, 272–277 CrossRef CAS . 48- Q. Zhang, K. Salnikow, T. Kluz, L. Chen, W. Su and M. Costa, Inhibition and reversal of nickel-induced transformation by the.